Citations (157)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Efstathia Davoutis, Chrysa Panou, Nikolina Stachika, Christina Dalla & Nikolaos Kokras. (2023) Drug-drug interactions between COVID-19 drug therapies and antidepressants. Expert Opinion on Drug Metabolism & Toxicology 0:0, pages 1-14.
Read now
Read now
Innocent G Asiimwe & Munir Pirmohamed. (2022) Drug–Drug–Gene Interactions in Cardiovascular Medicine. Pharmacogenomics and Personalized Medicine 15, pages 879-911.
Read now
Read now
Kazeem Adeola Oshikoya, Ibrahim Adekunle Oreagba, Brian Godman, Fisayo Solomon Oguntayo, Joseph Fadare, Samuel Orubu, Amos Massele & Idowu Odunayo Senbanjo. (2016) Potential drug-drug interactions in paediatric outpatient prescriptions in Nigeria and implications for the future. Expert Review of Clinical Pharmacology 9:11, pages 1505-1515.
Read now
Read now
Articles from other publishers (154)
Yi Shi, Chien-Wei Chiang, Kathleen T. Unroe, Ximena Oyarzun-Gonzalez, Anna Sun, Yuedi Yang, Katherine M. Hunold, Jeffrey Caterino, Lang Li, Macarius Donneyong & Pengyue Zhang. (2023) Application of an Innovative Data Mining Approach Towards Safe Polypharmacy Practice in Older Adults. Drug Safety.
Crossref
Crossref
Salwa Selim Ibrahim Abougalambou & Tief Naif Alenezi. (2023) Knowledge and information sources of potential drug–drug interactions of healthcare professionals among Buraydah Hospitals. Journal of Pharmaceutical Policy and Practice 16:1.
Crossref
Crossref
Mehrdad Karajizadeh, Farid Zand, Afsaneh Vazin, Hamid Reza Saeidnia, Brady D. Lund, Sai Priya Tummuru & Roxana Sharifian. (2023) Design, development, implementation, and evaluation of a severe drug–drug interaction alert system in the ICU: An analysis of acceptance and override rates. International Journal of Medical Informatics 177, pages 105135.
Crossref
Crossref
Sujit Kumar Sah, Subramanian Ramaswamy & Madhan Ramesh. (2023) “Assessment of potential drug-drug interactions and their associated risk factor in patients with rheumatoid arthritis: A cross-sectional study”. Clinical Epidemiology and Global Health 23, pages 101373.
Crossref
Crossref
Kamila Sienkiewicz, Monika Burzyńska, Izabela Rydlewska-Liszkowska, Jacek Sienkiewicz & Ewelina Gaszyńska. (2023) Indirect and Direct 65+ Patient Reporting of Non-Steroidal Anti-Inflammatory Drug-Induced Adverse Drug Reactions as a Source of Information on Polypharmacy and Polypharmacy-Related Risk. Medicina 59:9, pages 1585.
Crossref
Crossref
Eyal Mazuz, Guy Shtar, Nir Kutsky, Lior Rokach & Bracha Shapira. (2023) Pretrained transformer models for predicting the withdrawal of drugs from the market. Bioinformatics 39:8.
Crossref
Crossref
Karla M. Tamez-Torres, Norma Mongua-Rodríguez, Leticia Ferreyra-Reyes, Pedro Torres-Gonzalez, Guadalupe Delgado-Sánchez, Maribel Martínez-Hernández, Miriam Bobadilla-del-Valle, Velma Y. Jasso-Sosa, Priscila del S. López-Castillo, Elizabeth Ferreira-Guerrero, Luis Pablo Cruz-Hervert, Jose Sifuentes-Osornio, Carlos A. Aguilar-Salinas, Lourdes García-García & Alfredo Ponce-de-Leon. (2023) Safety and Tolerability of Six Months of Isoniazid Plus Pyridoxine or Three Months of Rifampicin for Tuberculosis among Subjects with Diabetes Mellitus: A Randomized Trial. Microorganisms 11:8, pages 1917.
Crossref
Crossref
James H. B. Im, Susan E. Bronskill, Rachel Strauss, Andrea Gruneir, Jun Guan, Alexa Boblitz, Mindy Lu, Paula A. Rochon & Rachel D. Savage. (2023) Sex‐based differences in the association between loneliness and polypharmacy among older adults in Ontario, Canada. Journal of the American Geriatrics Society.
Crossref
Crossref
Weixin Xie, Kunjie Fan, Shijun Zhang & Lang Li. (2023) Multiple sampling schemes and deep learning improve active learning performance in drug-drug interaction information retrieval analysis from the literature. Journal of Biomedical Semantics 14:1.
Crossref
Crossref
Mariana Bandeira-de Oliveira, Teresa Aparicio-González, Isabel del Cura-González, Carmen Suárez-Fernández, Ricardo Rodríguez-Barrientos & Jaime Barrio-Cortes. (2023) Adjusted morbidity groups and survival: a retrospective cohort study of primary care patients with chronic conditions. BMC Primary Care 24:1.
Crossref
Crossref
Thiyahiny S. Navaratinaraja, Thirunavukarasu Kumanan, Suthasini Siraj & Nadarajah Sreeharan. (2022) Potential Drug–Drug Interactions Among Hospitalised Elderly Patients in Northern Sri Lanka, A Lower Middle-Income Country: A Retrospective Analysis. Drugs - Real World Outcomes 10:1, pages 83-95.
Crossref
Crossref
Zuzana Očovská, Martina Maříková & Jiří Vlček. (2023) Potentially clinically significant drug-drug interactions in older patients admitted to the hospital: A cross-sectional study. Frontiers in Pharmacology 14.
Crossref
Crossref
Cvetka Bačar Bole, Katja Nagode, Mitja Pišlar, Aleš Mrhar, Iztok Grabnar & Tomaž Vovk. (2023) Potential Drug-Drug Interactions among Patients with Schizophrenia Spectrum Disorders: Prevalence, Association with Risk Factors, and Replicate Analysis in 2021. Medicina 59:2, pages 284.
Crossref
Crossref
Manfred Hauben. (2023) Artificial Intelligence and Data Mining for the Pharmacovigilance of Drug–Drug Interactions. Clinical Therapeutics 45:2, pages 117-133.
Crossref
Crossref
John E. Hughes, Catherine Waldron, Kathleen E. Bennett & Caitriona Cahir. (2023) Prevalence of Drug–Drug Interactions in Older Community-Dwelling Individuals: A Systematic Review and Meta-analysis. Drugs & Aging 40:2, pages 117-134.
Crossref
Crossref
Aldi Suryaman, Mohammad Bakhriansyah, Intan Yustikasari, Pandji Winata Nurikhwan & Dwi Laksono Adiputro. (2023) Risk of Adverse Drug-Drug Interactions in Heart Failure Patients with Co-morbidity Chronic Kidney Disease Prescribed Polypharmacy. BIO Web of Conferences 75, pages 05016.
Crossref
Crossref
Yaser Mohammed Al-Worafi, Long Chiau Ming, Abdullah Ahmed Dhabali, Abdulkareem Mohammed Al-Shami & Ammar Ali Saleh Jaber. 2023. Clinical Case Studies on Medication Safety. Clinical Case Studies on Medication Safety
199
223
.
Eline M. de Koning, Jeannine Huisbrink & Wilma Knol. 2023. Optimizing Pharmacotherapy in Older Patients. Optimizing Pharmacotherapy in Older Patients
33
46
.
Greet Van De Sijpe, Charlotte Quintens, Karolien Walgraeve, Eva Van Laer, Jens Penny, Greet De Vlieger, Rik Schrijvers, Paul De Munter, Veerle Foulon, Minne Casteels, Lorenz Van der Linden & Isabel Spriet. (2022) Overall performance of a drug–drug interaction clinical decision support system: quantitative evaluation and end-user survey. BMC Medical Informatics and Decision Making 22:1.
Crossref
Crossref
Fan Wu, Yan Wang, Quanxi Mei, Qinhua Chen, Chengpeng Sun, Xia Lv, Lei Feng, Chao Wang, Yanyan Zhang, Bangjiang Fang, Xiaokui Huo, Xiangge Tian & Xiaochi Ma. (2022) UGTs-mediated metabolic interactions contribute to enhanced anti-inflammation activity of Jinhongtang. Journal of Ethnopharmacology, pages 116016.
Crossref
Crossref
Yan Jin, Yang Li, Eric D. Eisenmann, William D. Figg, Sharyn D. Baker, Alex Sparreboom & Shuiying Hu. (2022) Determination of the endogenous OATP1B biomarkers glycochenodeoxycholate-3-sulfate and chenodeoxycholate-24-glucuronide in human and mouse plasma by a validated UHPLC-MS/MS method. Journal of Chromatography B 1210, pages 123437.
Crossref
Crossref
Jiacheng Chen, Xia Sun, Xin Jin & Richard Sutcliffe. (2022) Extracting drug–drug interactions from no-blinding texts using key semantic sentences and GHM loss. Journal of Biomedical Informatics 135, pages 104192.
Crossref
Crossref
Elpida Kontsioti, Simon Maskell, Amina Bensalem, Bhaskar Dutta & Munir Pirmohamed. (2022) Similarity and consistency assessment of three major online drug–drug interaction resources. British Journal of Clinical Pharmacology 88:9, pages 4067-4079.
Crossref
Crossref
Mei Zhao, Chuan-Fen Liu, Yu-Fei Feng & Hong Chen. (2022) Potential drug-drug interactions in drug therapy for older adults with chronic coronary syndrome at hospital discharge: A real-world study. Frontiers in Pharmacology 13.
Crossref
Crossref
Huaqiao Jiang, Yanhua Lin, Weifang Ren, Zhonghong Fang, Yujuan Liu, Xiaofang Tan, Xiaoqun Lv & Ning Zhang. (2022) Adverse drug reactions and correlations with drug–drug interactions: A retrospective study of reports from 2011 to 2020. Frontiers in Pharmacology 13.
Crossref
Crossref
Mathilde Bories, Guillaume Bouzillé, Marc Cuggia & Pascal Le Corre. (2022) Drug–Drug Interactions with Oral Anticoagulants as Potentially Inappropriate Medications: Prevalence and Outcomes in Elderly Patients in Primary Care and Hospital Settings. Pharmaceutics 14:7, pages 1410.
Crossref
Crossref
Duc Anh Nguyen, Canh Hao Nguyen, Peter Petschner & Hiroshi Mamitsuka. (2022) SPARSE: a sparse hypergraph neural network for learning multiple types of latent combinations to accurately predict drug–drug interactions. Bioinformatics 38:Supplement_1, pages i333-i341.
Crossref
Crossref
Louis Letinier, Iris Pujade, Perrine Duthoit, Grégoire Evrard, Francesco Salvo, Cédric Gil‐Jardine & Antoine Pariente. (2022) Emergency department admissions induced by drug–drug interactions in the elderly: A cross‐sectional study. Clinical and Translational Science 15:6, pages 1472-1481.
Crossref
Crossref
Lei Wang, Aditi Shendre, Chien‐Wei Chiang, Weidan Cao, Xia Ning, Ping Zhang, Pengyue Zhang & Lang Li. (2021) A pharmacovigilance study of pharmacokinetic drug interactions using a translational informatics discovery approach. British Journal of Clinical Pharmacology 88:4, pages 1471-1481.
Crossref
Crossref
N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov & V. M. Bakhtin. (2022) Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients. Rational Pharmacotherapy in Cardiology 18:1, pages 20-26.
Crossref
Crossref
Elpida Kontsioti, Simon Maskell, Bhaskar Dutta & Munir Pirmohamed. (2022) A reference set of clinically relevant adverse drug-drug interactions. Scientific Data 9:1.
Crossref
Crossref
H. Prely, C. Herledan, A. G. Caffin, A. Baudouin, V. Larbre, M. Maire, V. Schwiertz, N. Vantard, F. Ranchon & C. Rioufol. (2021) Real-life drug–drug and herb–drug interactions in outpatients taking oral anticancer drugs: comparison with databases. Journal of Cancer Research and Clinical Oncology 148:3, pages 707-718.
Crossref
Crossref
Ana V. Pejčić, Slobodan M. Janković & Goran Davidović. (2022) Risk factors for potential drug-drug interactions of statins in patients with acute coronary syndrome. Brazilian Journal of Pharmaceutical Sciences 58.
Crossref
Crossref
Samuel Berihun Dagnew, Tesfaye Yimer Tadesse, Mulugeta Molla Zeleke, Tesfagegn Gobezie Yiblet, Getu Tesfaw Addis, Gashaw Binega Mekonnen, Samuel Agegnew Wondm & Erkihun Assefa Negash. (2022) Drug–drug interactions among hospitalized elderly in patients at medical wards of Northwest Ethiopia’s Comprehensive Specialized Hospitals: A multicenter observational study. SAGE Open Medicine 10, pages 205031212211358.
Crossref
Crossref
Jane Louisa Debus, Paula Bachmann, Niklas Frahm, Pegah Mashhadiakbar, Silvan Elias Langhorst, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Michael Hecker & Uwe Klaus Zettl. (2022) Associated factors of potential drug-drug interactions and drug–food interactions in patients with multiple sclerosis. Therapeutic Advances in Chronic Disease 13, pages 204062232211083.
Crossref
Crossref
Samman Munir, Kanwal Rehman, Sajjad Ashraf, Rubab Akbar, Aqsa Shahid, Muhammad Atif Nisar & Mohsin Khurshid. 2022. Biochemistry of Drug Metabolizing Enzymes. Biochemistry of Drug Metabolizing Enzymes
347
374
.
Ramón Cacabelos, Vinogran Naidoo, Olaia Martínez-Iglesias, Lola Corzo, Natalia Cacabelos, Rocío Pego & Juan C. Carril. 2022. Pharmacogenomics in Drug Discovery and Development. Pharmacogenomics in Drug Discovery and Development
275
387
.
Ramón Cacabelos, Vinogran Naidoo, Lola Corzo, Natalia Cacabelos & Juan C. Carril. (2021) Genophenotypic Factors and Pharmacogenomics in Adverse Drug Reactions. International Journal of Molecular Sciences 22:24, pages 13302.
Crossref
Crossref
Lorène Zerah, Séverine Henrard, Ingeborg Wilting, Denis O’Mahony, Nicolas Rodondi, Olivia Dalleur, Kieran Dalton, Wilma Knol, Manuel Haschke & Anne Spinewine. (2021) Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial. BMC Geriatrics 21:1.
Crossref
Crossref
Yoshihiro Noguchi, Tomoya Tachi & Hitomi Teramachi. (2021) Detection algorithms and attentive points of safety signal using spontaneous reporting systems as a clinical data source. Briefings in Bioinformatics 22:6.
Crossref
Crossref
Scott Monteith & Tasha Glenn. (2021) Comparison of potential psychiatric drug interactions in six drug interaction database programs: A replication study after 2 years of updates. Human Psychopharmacology: Clinical and Experimental 36:6.
Crossref
Crossref
Thomas J Reese, Guilherme Del Fiol, Keaton Morgan, Jason T Hurwitz, Kensaku Kawamoto, Ainhoa Gomez-Lumbreras, Mary L Brown, Henrik Thiess, Sara R Vazquez, Scott D Nelson, Richard Boyce & Daniel Malone. (2021) A Shared Decision-making Tool for Drug Interactions Between Warfarin and Nonsteroidal Anti-inflammatory Drugs: Design and Usability Study. JMIR Human Factors 8:4, pages e28618.
Crossref
Crossref
Hans Kristian Råket Pedersen, Anne Mette Skov Sørensen, Astrid Blicher Schelde, Martin Erik Nyeland & Espen Jimenez-Solem. (2021) Prevalence and characteristics of drug-drug interactions among hospitalised patients in the Capital Region of Denmark. Adverse Drug Reaction Bulletin 330:1, pages 1279-1282.
Crossref
Crossref
Wei Lin, Mingyue Zheng, Yunhui Chen, Qian He, Adeel Khoja, Mingyue Long, Jiaxin Fan, Yiwen Hao, Chaomei Fu, Peng Hu, Ke Wang, Jianhua Jiang & Xuan Zhao. (2021) Dose Correlation of Panax ginseng and Atractylodes macrocephala Koidz. Drug Pairs in the Chinese Medicine Prescription Based on the Copula Function. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-14.
Crossref
Crossref
Ainash Ibysheva, Gulmira Muldaeva, Leila I. Arystan, Almagul B. Kuzgibekova, Bibigul A. Abeuova & Leila S. Haydargalieva. (2021) The Prevalence of Potentially Inappropriate Prescribing in the Elderly at the Primary Care Level in Kazakhstan. Open Access Macedonian Journal of Medical Sciences 9:A, pages 572-578.
Crossref
Crossref
John Peabody, Joshua Schrecker, Rebecca Heltsley, David Paculdo, Enrico de Belen, Diana Tamondong-Lachica, M. Czarina Acelajado, Othman Ouenes, Trina Kennedy & Elaine Jeter. (2021) Randomized Trial to Improve Primary Care Patient Management and Patient Outcomes Using a Drug–Drug Interaction Test: Confirmation of the DECART Simulated Patient Clinical Utility Trial Results. Diagnostics 11:7, pages 1266.
Crossref
Crossref
Patrick Wu, Scott D Nelson, Juan Zhao, Cosby A Stone Jr, QiPing Feng, Qingxia Chen, Eric A Larson, Bingshan Li, Nancy J Cox, C Michael Stein, Elizabeth J Phillips, Dan M Roden, Joshua C Denny & Wei-Qi Wei. (2021) DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions. Journal of the American Medical Informatics Association 28:7, pages 1421-1430.
Crossref
Crossref
Justin Q. Ly, Susan Wong, Liling Liu, Ruina Li, Kirsten Messick & Jae H. Chang. (2021) Investigating the Utility of Humanized Pregnane X Receptor-Constitutive Androstane Receptor-CYP3A4/7 Mouse Model to Assess CYP3A-Mediated Induction. Drug Metabolism and Disposition 49:7, pages 540-547.
Crossref
Crossref
Daniel Gonzalez & Jaydeep Sinha. (2021) Pediatric Drug‐Drug Interaction Evaluation: Drug, Patient Population, and Methodological Considerations. The Journal of Clinical Pharmacology 61:S1.
Crossref
Crossref
Weixin Xie, Limei Wang, Qi Cheng, Xueying Wang, Ying Wang, Hongyuan Bi, Bo He & Weixing Feng. (2021) Integrated Random Negative Sampling and Uncertainty Sampling in Active Learning Improve Clinical Drug Safety Drug–Drug Interaction Information Retrieval. Frontiers in Pharmacology 11.
Crossref
Crossref
Louis Létinier, Amandine Ferreira, Alexandre Marceron, Marina Babin, Joëlle Micallef, Ghada Miremont-Salamé & Antoine Pariente. (2021) Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database. Frontiers in Pharmacology 11.
Crossref
Crossref
Chun Yen Lee & Yi-Ping Phoebe Chen. (2021) Prediction of drug adverse events using deep learning in pharmaceutical discovery. Briefings in Bioinformatics 22:2, pages 1884-1901.
Crossref
Crossref
Harry Hochheiser, Xia Jing, Elizabeth A. Garcia, Serkan Ayvaz, Ratnesh Sahay, Michel Dumontier, Juan M. Banda, Oya Beyan, Mathias Brochhausen, Evan Draper, Sam Habiel, Oktie Hassanzadeh, Maria Herrero-Zazo, Brian Hocum, John Horn, Brian LeBaron, Daniel C. Malone, Øystein Nytrø, Thomas Reese, Katrina Romagnoli, Jodi Schneider, Louisa (Yu) Zhang & Richard D. Boyce. (2021) A Minimal Information Model for Potential Drug-Drug Interactions. Frontiers in Pharmacology 11.
Crossref
Crossref
Laila KVDr.Dr., Fathima Habeeba TEMohamed Musthafa ADr.Dr., Jobin LouisDr.Dr., Madeeha HabeebullaDr.Dr. & Mohammed Muneersha TK. (2021) EVALUATION OF ADVERSE DRUG REACTIONS IN A TERTIARY CARE CENTER IN SOUTH INDIA-A PROSPECTIVE OBSERVATIONAL STUDY. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH, pages 1-3.
Crossref
Crossref
Eric Chou, Richard D Boyce, Baran Balkan, Vignesh Subbian, Andrew Romero, Philip D Hansten, John R Horn, Sheila Gephart & Daniel C Malone. (2021) Designing and evaluating contextualized drug–drug interaction algorithms. JAMIA Open 4:1.
Crossref
Crossref
Erika Fleming & Yangchao Luo. (2021) Co-delivery of synergistic antioxidants from food sources for the prevention of oxidative stress. Journal of Agriculture and Food Research 3, pages 100107.
Crossref
Crossref
Mathilde Bories, Guillaume Bouzillé, Marc Cuggia & Pascal Le Corre. (2021) Drug–Drug Interactions in Elderly Patients with Potentially Inappropriate Medications in Primary Care, Nursing Home and Hospital Settings: A Systematic Review and a Preliminary Study. Pharmaceutics 13:2, pages 266.
Crossref
Crossref
Sofia Burato, Luca Leonardi, Ippazio Cosimo Antonazzo, Emanuel Raschi, Chiara Ajolfi, Manuela Baraghini, Antonella Chiarello, Valentina Delmonte, Lucio Di Castri, Monia Donati, Antonella Fadda, Daniela Fedele, Alessandra Ferretti, Laura Gabrielli, Silvia Gobbi, Sereno Lughi, Martina Mazzari, Fabio Pieraccini, Alessandro Renzetti, Elsa Russi, Chiara Scanelli, Barbara Zanetti & Elisabetta Poluzzi. (2021) Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region. Frontiers in Pharmacology 11.
Crossref
Crossref
Lara Magro, Elena Arzenton, Roberto Leone, Marilisa Giustina Stano, Michele Vezzaro, Annette Rudolph, Irene Castagna & Ugo Moretti. (2021) Identifying and Characterizing Serious Adverse Drug Reactions Associated With Drug-Drug Interactions in a Spontaneous Reporting Database. Frontiers in Pharmacology 11.
Crossref
Crossref
Luciana Mello de Oliveira, Juliana do Amaral Carneiro Diel, Alessandra Nunes & Tatiane da Silva Dal Pizzol. (2021) Prevalence of drug interactions in hospitalised elderly patients: a systematic review. European Journal of Hospital Pharmacy 28:1, pages 4-9.
Crossref
Crossref
Anna A. Gruzdeva, Alexander L. Khokhlov & Mikhail V. Ilyin. (2020) Risk management strategy for preventing the reduced treatment effectiveness from the position of drug interactions and polypharmacy in patients with coronary heart disease. Research Results in Pharmacology 6:4, pages 85-92.
Crossref
Crossref
R. M. Turner, E. M. de Koning, V. Fontana, A. Thompson & M. Pirmohamed. (2020) Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study. BMC Medicine 18:1.
Crossref
Crossref
Christina Dornquast, Mirja Dombrowski, Markus Zabel, Stefan N. Willich & Thomas Reinhold. (2020) Potential drug-drug interactions in patients with indication for prophylactic implantation of a cardioverter defibrillator: a cross-sectional analysis. BMC Health Services Research 20:1.
Crossref
Crossref
Prosperity C. Eneh, Katherine Huppler Hullsiek, Daniel Kiiza, Joshua Rhein, David B. Meya, David R. Boulware & Melanie R. Nicol. (2020) Prevalence and nature of potential drug-drug interactions among hospitalized HIV patients presenting with suspected meningitis in Uganda. BMC Infectious Diseases 20:1.
Crossref
Crossref
Ang Wen, Xiaoyan Sun, Kai Yu, Yingfei Wu, Jia Zhang & Zhenming Yuan. (2020) Drug-Drug Interaction Extraction using Pre-training Model of Enhanced Entity Information. Drug-Drug Interaction Extraction using Pre-training Model of Enhanced Entity Information.
K. Todorova-Nenova, M. Zhelyazkova-Savova & S. Gancheva. (2020) P.456 Evaluation of potential drug-drug interactions in psychiatric patients. European Neuropsychopharmacology 40, pages S258-S259.
Crossref
Crossref
Charles E. Leonard, Colleen M. Brensinger, Thanh Phuong Pham Nguyen, John R. Horn, Sophie Chung, Warren B. Bilker, Sascha Dublin, Samantha E. Soprano, Ghadeer K. Dawwas, David W. Oslin, Douglas J. Wiebe & Sean Hennessy. (2020) Screening to identify signals of opioid drug interactions leading to unintentional traumatic injury. Biomedicine & Pharmacotherapy 130, pages 110531.
Crossref
Crossref
Dominique A. Garrison, Zahra Talebi, Eric D. Eisenmann, Alex Sparreboom & Sharyn D. Baker. (2020) Role of OATP1B1 and OATP1B3 in Drug-Drug Interactions Mediated by Tyrosine Kinase Inhibitors. Pharmaceutics 12:9, pages 856.
Crossref
Crossref
Scott Monteith, Tasha Glenn, Michael Gitlin & Michael Bauer. (2020) Potential Drug interactions with Drugs used for Bipolar Disorder: A Comparison of 6 Drug Interaction Database Programs. Pharmacopsychiatry 53:05, pages 220-227.
Crossref
Crossref
Weifang Ren, Yujuan Liu, Jun Zhang, Zhonghong Fang, Huan Fang, Yuan Gong & Xiaoqun Lv. (2020) Prevalence of potential drug–drug interactions in outpatients of a general hospital in China: a retrospective investigation. International Journal of Clinical Pharmacy 42:4, pages 1190-1196.
Crossref
Crossref
Lixiang Hong, Jinjian Lin, Shuya Li, Fangping Wan, Hui Yang, Tao Jiang, Dan Zhao & Jianyang Zeng. (2020) A novel machine learning framework for automated biomedical relation extraction from large-scale literature repositories. Nature Machine Intelligence 2:6, pages 347-355.
Crossref
Crossref
Mustafa Adnan Malki & Ewan Robert Pearson. (2019) Drug–drug–gene interactions and adverse drug reactions. The Pharmacogenomics Journal 20:3, pages 355-366.
Crossref
Crossref
Fabiola Medina-Barajas, Estefanía Vázquez-Méndez, Edsaúl Emilio Pérez-Guerrero, Virginia Aleyda Sánchez-López, Iván I. Hernández-Cañaveral, Real-Ornelas Gabriel A & Selene G. Huerta-Olvera. (2020) Pilot study: Evaluation of potential drug–drug interactions in hospitalized pediatric patients. Pediatrics & Neonatology 61:3, pages 279-289.
Crossref
Crossref
Anqi Zhu, Donglin Zeng, Li Shen, Xia Ning, Lang Li & Pengyue Zhang. (2020) A super‐combo‐drug test to detect adverse drug events and drug interactions from electronic health records in the era of polypharmacy. Statistics in Medicine 39:10, pages 1458-1472.
Crossref
Crossref
Muh. Akbar Bahar, Jens H. J. Bos, Sander D. Borgsteede, Aafje Dotinga, Rolinde A. Alingh, Bob Wilffert & Eelko Hak. (2020) Prevalence and Accuracy of Information on CYP2D6, CYP2C19, and CYP2C9 Related Substrate and Inhibitor Co-Prescriptions in the General Population: A Cross‐Sectional Descriptive Study as Part of the PharmLines Initiative. Frontiers in Pharmacology 11.
Crossref
Crossref
Milena Kovačević, Sandra Vezmar Kovačević, Slavica Radovanović, Predrag Stevanović & Branislava Miljković. (2019) Potential drug–drug interactions associated with clinical and laboratory findings at hospital admission. International Journal of Clinical Pharmacy 42:1, pages 150-157.
Crossref
Crossref
Sumanjali J. V. Daggupati, PU Prakash Saxena, Ashwin Kamath & Mukta N. Chowta. (2019) Drug–drug interactions in patients undergoing chemoradiotherapy and the impact of an expert team intervention. International Journal of Clinical Pharmacy 42:1, pages 132-140.
Crossref
Crossref
Courtney A Polenick, Sarah D Stanz, Amanda N Leggett, Donovan T Maust, Nancy A Hodgson & Helen C Kales. (2020) Stressors and Resources Related to Medication Management: Associations With Spousal Caregivers’ Role Overload. The Gerontologist 60:1, pages 165-173.
Crossref
Crossref
José Luis Garduño Hernández. (2020) Interacciones farmacológicas potenciales en pacientes ambulatorios en expedientes de queja médica de la CONAMED. Revista CONAMED 25:3, pages 115-122.
Crossref
Crossref
Maria Lígia Silva Nunes Cavalcante, Renata Kelly Lopes de Alcântara, Isabelly Costa Lima de Oliveira, Samia Freitas Aires, Ana Lívia Araújo Girão & Rhanna Emanuela Fontenele Lima de Carvalho. (2020) Drug safety among institutionalized elderly people: potential interactions. Escola Anna Nery 24:1.
Crossref
Crossref
Natalia B. Lazareva, Evgenia V. Shikh, Ekaterina V. Rebrova & Anastasia Yu. Ryazanova. (2019) Polypharmacy in Pediatrics: Modern Conditions. Current Pediatrics 18:3, pages 212-218.
Crossref
Crossref
Kevin T Bain, Adriana Matos, Calvin H Knowlton & David McGain. (2019) Genetic variants and interactions from a pharmacist-led pharmacogenomics service for PACE. Pharmacogenomics 20:10, pages 709-718.
Crossref
Crossref
Aigul Z. Mussina, Gaziza A. Smagulova, Galina V. Veklenko, Bibigul B. Tleumagambetova, Nazgul A. Seitmaganbetova, Aigul A. Zhaubatyrova & Lazzat M. Zhamaliyeva. (2019) Effect of an educational intervention on the number potential drug-drug interactions. Saudi Pharmaceutical Journal 27:5, pages 717-723.
Crossref
Crossref
Robert B. Raffa, Robert TaylorJr.Jr. & Joseph V. PergolizziJr.Jr.. (2019) Treating opioid‐induced constipation in patients taking other medications: Avoiding CYP450 drug interactions. Journal of Clinical Pharmacy and Therapeutics 44:3, pages 361-371.
Crossref
Crossref
Scott Monteith & Tasha Glenn. (2019) A comparison of potential psychiatric drug interactions from six drug interaction database programs. Psychiatry Research 275, pages 366-372.
Crossref
Crossref
Ana V. Pejčić, Slobodan M. Janković & Goran Davidović. (2018) Drug–drug interactions in patients with acute coronary syndrome across phases of treatment. Internal and Emergency Medicine 14:3, pages 411-422.
Crossref
Crossref
Enrica Cecchi. (2019) Drug–drug interaction knowledge to save the patient from iatrogenic disease and to improve the diagnostic process. Internal and Emergency Medicine 14:3, pages 345-347.
Crossref
Crossref
Jing‐Xian Zhang, Mei‐Juan Qi, Mei‐Zhi Shi, Jun‐Jun Chen, Xiang‐Qi Zhang, Jiao Yang, Ke‐Zhi Zhang, Yong‐Long Han & Cheng Guo. (2018)
Effects of Danhong injection, a traditional Chinese medicine, on nine cytochrome P450 isoforms
in vitro
. Biomedical Chromatography 33:4.
Crossref
Crossref
Louis Létinier, Sébastien Cossin, Yohann Mansiaux, Mickaël Arnaud, Francesco Salvo, Julien Bezin, Frantz Thiessard & Antoine Pariente. (2019) Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study. Frontiers in Pharmacology 10.
Crossref
Crossref
L.A. Hoehn, J. Faros Barros, J. Desmeules & K. Ing-Lorenzini. (2019) Importance des interactions médicamenteuses néfastes chez le patient oncologique : comparaison de programmes de détection informatisés. Douleur et Analgésie 32:1, pages 21-36.
Crossref
Crossref
Xia Sun, Ke Dong, Long Ma, Richard Sutcliffe, Feijuan He, Sushing Chen & Jun Feng. (2019) Drug-Drug Interaction Extraction via Recurrent Hybrid Convolutional Neural Networks with an Improved Focal Loss. Entropy 21:1, pages 37.
Crossref
Crossref
Uwe FuhrChih-hsuan HsinXia LiWafaâ JabraneFritz Sörgel. (2019) Assessment of Pharmacokinetic Drug–Drug Interactions in Humans: In Vivo Probe Substrates for Drug Metabolism and Drug Transport Revisited. Annual Review of Pharmacology and Toxicology 59:1, pages 507-536.
Crossref
Crossref
O. O. Kirilochev & A. R. Umerova. (2019) Safety of psychopharmacotherapy: a clinical and pharmacological approach. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 119:10, pages 127.
Crossref
Crossref
Netsanet Diksis, Tsegaye Melaku, Desta Assefa & Andualem Tesfaye. (2019) Potential drug–drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia. SAGE Open Medicine 7, pages 205031211985735.
Crossref
Crossref
Jennifer Panich, Andrea Gooden, F. Mazda Shirazi & Daniel C. Malone. (2019) Warnings for drug–drug interactions in consumer medication information provided by community pharmacies. Journal of the American Pharmacists Association 59:1, pages 35-42.
Crossref
Crossref
Mohammad Ismail, Sidra Noor, Umme Harram, Inamul Haq, Iqbal Haider, Faiza Khadim, Qasim Khan, Zahid Ali, Tahir Muhammad & Muhammad Asif. (2018) Potential drug-drug interactions in outpatient department of a tertiary care hospital in Pakistan: a cross-sectional study. BMC Health Services Research 18:1.
Crossref
Crossref
Renée J. G. Arnold, Jun Tang, Joshua Schrecker & Cheryl Hild. (2018) Impact of Definitive Drug–Drug Interaction Testing on Medication Management and Patient Care. Drugs - Real World Outcomes 5:4, pages 217-224.
Crossref
Crossref
G. S. Krasnov & I. V. Kazancev. (2018) Excessive Hypocoagulation in Therapy with Warfarin within Polypharmacy: Using online database Multi-Drug Interaction Checker and Graphic “Time-Effect-Drug Administration” to Eliminate Adverse Drug Event (Case Report). Rational Pharmacotherapy in Cardiology 14:5, pages 687-690.
Crossref
Crossref
Nadine Sbaih, Brian Buss, Dheeraj Goyal, Sowmya R Rao, Russell Benefield, Allison Taylor Walker, Douglas H Esposito, Edward T Ryan, Regina C LaRocque, Daniel T Leung, George M Abraham, Salvador Alvarez, Vernon Ansdell, Johnnie A Yates, Elisha H Atkins, Holly K Birich, Dagmar Vitek, John Cahill, Lin Chen, Bradley A Connor, Roberta Dismukes, Jessica Fairley, Phyllis Kozarsky, Henry Wu, Ronke Dosunmu, Jeffrey A Goad, Edith Mirzaian, Karl Hess, Noreen A Hynes, Frederique Jacquerioz, Susan McLellan, Jenn Katsolis, Paul Kelly, Mark Knouse, Jennifer Lee, Daniel Leung, Brian Kendall, DeVon Hale, Alawode Oladele, Hanna Demeke, Alawode Oladele, Althea Otuata, Roger Pasinski, Amy E Wheeler, Adrienne Showler, Laura Coster, Jessica Rosen, Brian S Schwartz, William Stauffer, Patricia Walker & Joseph Vinetz. (2018) Potentially Serious Drug Interactions Resulting From the Pretravel Health Encounter. Open Forum Infectious Diseases 5:11.
Crossref
Crossref
John Peabody, Mary Tran, David Paculdo, Joshua Schrecker, Czarlota Valdenor & Elaine Jeter. (2018) Clinical Utility of Definitive Drug–Drug Interaction Testing in Primary Care. Journal of Clinical Medicine 7:11, pages 384.
Crossref
Crossref
Santiago Vilar, Carol Friedman & George Hripcsak. (2018) Detection of drug–drug interactions through data mining studies using clinical sources, scientific literature and social media. Briefings in Bioinformatics 19:5, pages 863-877.
Crossref
Crossref
Maria Zhelyazkova-Savova, Koraliya Todorova-Nenova, Silviya Gancheva & Desislava Karadjova. (2018) Evaluation of potential drug-drug interactions in psychiatric patients: a pilot study. Scripta Scientifica Medica 50:3, pages 13.
Crossref
Crossref
Fabrizio Colombo, Pietro Nunnari, Giovanni Ceccarelli, Angelo Valerio Romano, Pietro Barbieri & Francesco Scaglione. (2018) Measures of Drug Prescribing at Care Transitions in an Internal Medicine Unit. The Journal of Clinical Pharmacology 58:9, pages 1171-1183.
Crossref
Crossref
Alice Ranzani, Letizia Oreni, Massimiliano Agrò, Lorena van den Bogaart, Laura Milazzo, Andrea Giacomelli, Dario Cattaneo, Cristina Gervasoni & Anna Lisa Ridolfo. (2018) Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older. JAIDS Journal of Acquired Immune Deficiency Syndromes 78:2, pages 193-201.
Crossref
Crossref
Janja Jazbar, Igor Locatelli, Nejc Horvat & Mitja Kos. (2018) Clinically relevant potential drug–drug interactions among outpatients: A nationwide database study. Research in Social and Administrative Pharmacy 14:6, pages 572-580.
Crossref
Crossref
Maryam Hassanzad, Sara Arenas-Lopez & Shadi Baniasadi. (2018) Potential Drug-Drug Interactions Among Critically Ill Pediatric Patients in a Tertiary Pulmonary Center. The Journal of Clinical Pharmacology 58:2, pages 221-227.
Crossref
Crossref
Sangrak Lim, Kyubum Lee & Jaewoo Kang. (2018) Drug drug interaction extraction from the literature using a recursive neural network. PLOS ONE 13:1, pages e0190926.
Crossref
Crossref
Ruifeng Liu, Mohamed Diwan M. AbdulHameed, Kamal Kumar, Xueping Yu, Anders Wallqvist & Jaques Reifman. (2017) Data-driven prediction of adverse drug reactions induced by drug-drug interactions. BMC Pharmacology and Toxicology 18:1.
Crossref
Crossref
Qasim Khan, Mohammad Ismail, Iqbal Haider & Fahadullah Khan. (2017) Prevalence of QT interval prolonging drug–drug interactions (QT-DDIs) in psychiatry wards of tertiary care hospitals in Pakistan: a multicenter cross-sectional study. International Journal of Clinical Pharmacy 39:6, pages 1256-1264.
Crossref
Crossref
Katie J. Quinn & Nigam H. Shah. (2017) A dataset quantifying polypharmacy in the United States. Scientific Data 4:1.
Crossref
Crossref
Milena Kovačević, Sandra Vezmar Kovačević, Branislava Miljković, Slavica Radovanović & Predrag Stevanović. (2017) The prevalence and preventability of potentially relevant drug-drug interactions in patients admitted for cardiovascular diseases: A cross-sectional study. International Journal of Clinical Practice 71:10, pages e13005.
Crossref
Crossref
Neža Muhič, Ales Mrhar & Miran Brvar. (2017) Comparative analysis of three drug–drug interaction screening systems against probable clinically relevant drug–drug interactions: a prospective cohort study. European Journal of Clinical Pharmacology 73:7, pages 875-882.
Crossref
Crossref
Susana Sánchez-Fidalgo, Maria Isabel Guzmán-Ramos, Mercedes Galván-Banqueri, Máximo Bernabeu-Wittel & Bernardo Santos-Ramos. (2017) Prevalence of drug interactions in elderly patients with multimorbidity in primary care. International Journal of Clinical Pharmacy 39:2, pages 343-353.
Crossref
Crossref
Yun-Chen Tien, Stephanie C. Piekos, Chad Pope & Xiao-bo Zhong. (2017) Phenobarbital Treatment at a Neonatal Age Results in Decreased Efficacy of Omeprazole in Adult Mice. Drug Metabolism and Disposition 45:3, pages 330-335.
Crossref
Crossref
O. O. Kirilochev, A. R. Umerova, I. P. Dorfman & A. V. Khryashchev. (2017) The drug-drug interactions in a psychiatric hospital. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 117:5, pages 26.
Crossref
Crossref
Aline Teotonio Rodrigues, Rebeca Stahlschmidt, Silvia Granja, Diogo Pilger, Antonio Luis Eiras Falcão & Priscila Gava Mazzola. (2017) Prevalence of potential drug-drug interactions in the intensive care unit of a Brazilian teaching hospital. Brazilian Journal of Pharmaceutical Sciences 53:1.
Crossref
Crossref
Dev Bukhsh Singh. 2017. Translational Bioinformatics and Its Application. Translational Bioinformatics and Its Application
299
333
.
D A Sychev, V A Otdelеnov, N M Krasnova & E S Ilyina. (2016) Polypragmasy: A clinical pharmacologist’s view. Terapevticheskii arkhiv 88:12, pages 94-102.
Crossref
Crossref
Fantaye Teka, Gebrehiwot Teklay, Eskindeir Ayalew & Terefe Teshome. (2016) Potential drug–drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study. BMC Research Notes 9:1.
Crossref
Crossref
Silvia Misasi, Giuliana Martini, Oriana Paoletti, Stefano Calza, Giovanni Scovoli, Alessandra Marengoni, Sophie Testa, Luigi Caimi & Eleonora Marchina. (2016) VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients. Medicine 95:52, pages e5451.
Crossref
Crossref
Shabbir Ahmed, Zhan Zhou, Jie Zhou & Shu-Qing Chen. (2016) Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine. Genomics, Proteomics & Bioinformatics 14:5, pages 298-313.
Crossref
Crossref
Debaleena Chattopadhyay, Romisa Rohani Ghahari, Jon Duke & Davide Bolchini. (2016) Understanding Advice Sharing among Physicians: Towards Trust-Based Clinical Alerts. Interacting with Computers 28:4, pages 532-551.
Crossref
Crossref
Henok Getachew, Mohammed Assen, Feser Dula & Akshaya Srikanth Bhagavathula. (2016) Potential drug–drug interactions in pediatric wards of Gondar University Hospital, Ethiopia: A cross sectional study. Asian Pacific Journal of Tropical Biomedicine 6:6, pages 534-538.
Crossref
Crossref
Harry Hochheiser, Yifan Ning, Andres Hernandez, John R Horn, Rebecca Jacobson & Richard D Boyce. (2016) Using Nonexperts for Annotating Pharmacokinetic Drug-Drug Interaction Mentions in Product Labeling: A Feasibility Study. JMIR Research Protocols 5:2, pages e40.
Crossref
Crossref
Emanuel Raschi, Carlo Piccinni, Vincenzo Signoretta, Lucio Lionello, Silvia Bonezzi, Marcello Delfino, Lucia Di Candia, Lucio Di Castri, Fabio Pieraccini, Daniela Carati, Elisabetta Poluzzi & Fabrizio De Ponti. (2015) Clinically important drug-drug interactions in poly-treated elderly outpatients: a campaign to improve appropriateness in general practice. British Journal of Clinical Pharmacology 80:6, pages 1411-1420.
Crossref
Crossref
Thomas H Payne, Lisa E. Hines, Raymond C Chan, Seth Hartman, Joan Kapusnik-Uner, Alissa L Russ, Bruce W Chaffee, Christian Hartman, Victoria Tamis, Brian Galbreth, Peter A Glassman, Shobha Phansalkar, Heleen van der Sijs, Sheila M Gephart, Gordon Mann, Howard R Strasberg, Amy J Grizzle, Mary Brown, Gilad J Kuperman, Chris Steiner, Amanda Sullins, Hugh Ryan, Michael A Wittie & Daniel C Malone. (2015) Recommendations to improve the usability of drug-drug interaction clinical decision support alerts. Journal of the American Medical Informatics Association 22:6, pages 1243-1250.
Crossref
Crossref
Delphine Abadie, Vanessa Rousseau, Sophie Logerot, Judith Cottin, Jean-Louis Montastruc & François Montastruc. (2015) Serotonin Syndrome. Journal of Clinical Psychopharmacology 35:4, pages 382-388.
Crossref
Crossref
Yee Kiat Heng & Yen Loo Lim. (2015) Cutaneous adverse drug reactions in the elderly. Current Opinion in Allergy & Clinical Immunology 15:4, pages 300-307.
Crossref
Crossref
Serkan Ayvaz, John Horn, Oktie Hassanzadeh, Qian Zhu, Johann Stan, Nicholas P. Tatonetti, Santiago Vilar, Mathias Brochhausen, Matthias Samwald, Majid Rastegar-Mojarad, Michel Dumontier & Richard D. Boyce. (2015) Toward a complete dataset of drug–drug interaction information from publicly available sources. Journal of Biomedical Informatics 55, pages 206-217.
Crossref
Crossref
Alexander Pfundner, Tobias Schönberg, John Horn, Richard D Boyce & Matthias Samwald. (2015) Utilizing the Wikidata System to Improve the Quality of Medical Content in Wikipedia in Diverse Languages: A Pilot Study. Journal of Medical Internet Research 17:5, pages e110.
Crossref
Crossref
Anne Pauly, Carolin Wolf, Marika Busse, Ann-Catrin Strauß, Sabine Krebs, Frank Dörje & Kristina Friedland. (2015) Evaluation of eight drug interaction databases commonly used in the German healthcare system. European Journal of Hospital Pharmacy 22:3, pages 165-170.
Crossref
Crossref
Luke Miller, Karen Steinmetz Pater & Shelby Corman. (2015) The role of clinical decision support in pharmacist response to drug-interaction alerts. Research in Social and Administrative Pharmacy 11:3, pages 480-486.
Crossref
Crossref
Richard T. Scheife, Lisa E. Hines, Richard D. Boyce, Sophie P. Chung, Jeremiah D. Momper, Christine D. Sommer, Darrell R. Abernethy, John R. Horn, Stephen J. Sklar, Samantha K. Wong, Gretchen Jones, Mary L. Brown, Amy J. Grizzle, Susan Comes, Tricia Lee Wilkins, Clarissa Borst, Michael A. Wittie & Daniel C. Malone. (2015) Consensus Recommendations for Systematic Evaluation of Drug–Drug Interaction Evidence for Clinical Decision Support. Drug Safety 38:2, pages 197-206.
Crossref
Crossref
James FeinsteinDingwei Dai, Wenjun Zhong, Jason Freedman & Chris Feudtner. (2015) Potential Drug−Drug Interactions in Infant, Child, and Adolescent Patients in Children’s Hospitals. Pediatrics 135:1, pages e99-e108.
Crossref
Crossref
William D. Simmons, Pamala A. Jacobson & Karen L. Hardinger. 2014. Textbook of Organ Transplantation. Textbook of Organ Transplantation
1242
1255
.
María Verónica Rey, Santiago Perez-Lloret, Anne Pavy-Le Traon, Wassilios G. Meissner, Francois Tison & Olivier Rascol. (2014) A Cross-Sectional Study on Drug Use in Multiple System Atrophy. CNS Drugs 28:5, pages 483-490.
Crossref
Crossref
Paul Verbeurgt, Tyler Mamiya & Jessica Oesterheld. (2014)
How common are drug and gene interactions? Prevalence in a sample of 1143 patients with
CYP2C9
,
CYP2C19
and
CYP2D6
genotyping
. Pharmacogenomics 15:5, pages 655-665.
Crossref
Crossref
Jean-Pascal Fournier, Agnès Sommet, Geneviève Durrieu, Jean-Christophe Poutrain, Maryse Lapeyre-Mestre & Jean-Louis Montastruc. (2014) Drug interactions between antihypertensive drugs and non-steroidal anti-inflammatory agents: a descriptive study using the French Pharmacovigilance database. Fundamental & Clinical Pharmacology 28:2, pages 230-235.
Crossref
Crossref
Heng-Yi Wu, Chien-Wei Chiang & Lang Li. 2014. Biomedical Literature Mining. Biomedical Literature Mining
47
75
.
Michael J. Armahizer, Sandra L. Kane-Gill, Pamela L. Smithburger, Ananth M. Anthes & Amy L. Seybert. (2013) Comparing Drug-Drug Interaction Severity Ratings between Bedside Clinicians and Proprietary Databases. ISRN Critical Care 2013, pages 1-6.
Crossref
Crossref
Mélanie Le Lay, Jean-Pascal Fournier & Jean-Louis Montastruc. (2013) Interactions médicamenteuses potentielles en médecine générale : comparaison de deux études transversales en 1997 et 2012. Therapies 68:6, pages 411-413.
Crossref
Crossref
Srecko Marusic, Vesna Bacic-Vrca, Paulo Roque Obreli Neto, Miljenko Franic, Viktorija Erdeljic & Nives Gojo-Tomic. (2013) Actual drug–drug interactions in elderly patients discharged from internal medicine clinic: a prospective observational study. European Journal of Clinical Pharmacology 69:9, pages 1717-1724.
Crossref
Crossref
Eva Montané, Anna López & Joan Costa. (2013) Características y diseño de los estudios que evalúan interacciones farmacológicas. Medicina Clínica 141:2, pages 82-86.
Crossref
Crossref
. (2013) Drug interactions result from a number of underlying pharmacokinetic and pharmacodynamic mechanisms. Drugs & Therapy Perspectives 29:7, pages 217-222.
Crossref
Crossref
Sigrid Narum, Vigdis Solhaug, Kirsten Myhr, Odd Brørs & Marianne Kristiansen Kringen. (2013) Characterisation of non-warfarin-associated bleeding events reported to the Norwegian spontaneous reporting system. European Journal of Clinical Pharmacology 69:7, pages 1445-1452.
Crossref
Crossref
Michael J. Armahizer, Amy L. Seybert, Pamela L. Smithburger & Sandra L. Kane-Gill. (2013) Drug-drug interactions contributing to QT prolongation in cardiac intensive care units. Journal of Critical Care 28:3, pages 243-249.
Crossref
Crossref
Anne Charlotte Danton, François Montastruc, Agnès Sommet, Geneviève Durrieu, Haleh Bagheri, Emmanuelle Bondon-Guitton, Maryse Lapeyre-Mestre & Jean-Louis Montastruc. (2012) Importance of cytochrome P450 (CYP450) in adverse drug reactions due to drug–drug interactions: a PharmacoVigilance study in France. European Journal of Clinical Pharmacology 69:4, pages 885-888.
Crossref
Crossref
J C Stingl, J Brockmöller & R Viviani. (2012) Genetic variability of drug-metabolizing enzymes: the dual impact on psychiatric therapy and regulation of brain function. Molecular Psychiatry 18:3, pages 273-287.
Crossref
Crossref
S. Decani, E. Baruzzi, V. Martini, G. Ficarra & G. Lodi. (2013) Reazioni awerse e interazioni farmacologiche di interesse odontoiatrico. Dental Cadmos 81:3, pages 124-135.
Crossref
Crossref
Jasper Dingemanse & Laurent Nicolas. (2013) Drug-Drug Interaction Study of ACT-178882, a New Renin Inhibitor, and Diltiazem in Healthy Subjects. Clinical Drug Investigation 33:3, pages 207-213.
Crossref
Crossref
Steven J. Bowlin, Fang Xia, Wenyi Wang, Keisha D. Robinson & Eric J. Stanek. (2013) Twelve-Month Frequency of Drug-Metabolizing Enzyme and Transporter-Based Drug-Drug Interaction Potential in Patients Receiving Oral Enzyme-Targeted Kinase Inhibitor Antineoplastic Agents. Mayo Clinic Proceedings 88:2, pages 139-148.
Crossref
Crossref
Linda Brewer & David Williams. (2013) Clinically Relevant Drug-Drug and Drug-Food Interactions. Pharmaceutical Medicine 27:1, pages 9-23.
Crossref
Crossref
Karmen Stankov, Ana Sabo & Momir Mikov. (2013) Pharmacogenetic Biomarkers as Tools for Pharmacoepidemiology of Severe Adverse Drug Reactions. Drug Development Research 74:1, pages 1-14.
Crossref
Crossref
Jessica L. Gören & Ashley Tewksbury. 2013. Polypharmacy in Psychiatry Practice, Volume I. Polypharmacy in Psychiatry Practice, Volume I
45
74
.